Join the Head and Neck Cancer group to help and get support from people like you.
Head and Neck Cancer News (Page 2)
Related terms: Oral Cancer
Cannabis-Related Disorder Linked to Risk for Head and Neck Cancer
MONDAY, Aug. 12, 2024 – Cannabis-related disorder is associated with an increased rate of head and neck cancer (HNC), according to a study published online Aug. 8 in JAMA Otolaryngology-Head & Neck...
Heavy Marijuana Use More Than Triples Odds for Head & Neck Cancers
THURSDAY, Aug. 8, 2024 – People who use marijuana at high levels are putting themselves at more than three times the risk for head and neck cancers, new research warns. The study is perhaps the most...
Higher Mortality, Less Improvement Seen for Rural Residents With Head, Neck Cancer
THURSDAY, July 11, 2024 – Compared with their urban counterparts, rural residents with head and neck cancer (HNC) have higher mortality rates and less annual improvement, according to a research...
Doctors Perform Larynx Transplant in Cancer Patient
WEDNESDAY, July 10, 2024 – For years, Marty Kedian had been without a voice. Kedian, who hails from Haverhill, Mass., has undergone dozens of surgeries while being treated for a rare form of...
Survey Shows Men Need to Do More to Prevent Cancer
FRIDAY, July 5, 2024 – American men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns. More than 6 in 10 (65%) men in the nationwide...
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
FRIDAY, June 28, 2024 – In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology, recommendations are...
Chemo Before, After Surgery Could Help Those Battling Esophageal Cancer
TUESDAY, June 4, 2024 (Healthday News) – People battling advanced esophageal cancers should get doses of chemotherapy both before and after tumor-removing surgeries, a new study suggests. “There is c...
FDA Approves Merck’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
KENILWORTH, N.J.--(BUSINESS WIRE) June 12, 2020 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Keytruda (pembrolizumab) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE) June 11, 2019 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Bristol-Myers Squibb’s Opdivo (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing
PRINCETON, N.J.--(BUSINESS WIRE) March 6, 2018 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License...
Bristol-Myers Squibb’s Opdivo (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
PRINCETON, N.J.--(BUSINESS WIRE) November 10, 2016 --Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab)...
FDA Approves Merck’s Keytruda (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE)--August 5, 2016 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
San Jose, Calif. - December 28, 2015 - Teikoku Pharma USA (TPU) announced today that the U.S. Food and Drug Administration ("FDA") has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel...
FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
SILVER SPRING, Md., Nov. 7, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage...